{
  "docId": "019dd923-5e88-73ef-bd5a-9cdc5d048fe2",
  "docSlug": "03e126adc7ca1480",
  "documentTitle": "20250114 bayer handout jpm 2025",
  "authorId": "JPMorgan",
  "authorName": "Bayer",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "equity_research",
  "sourceTypeLabel": "Equity research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 8,
  "pageCount": 18,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a stacked area chart visualization to represent portfolio evolution over time.",
  "elementsJson": [
    "headline_text",
    "area_chart",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5a-9cdc5d048fe2/8",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5a-9cdc5d048fe2",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5a-9cdc5d048fe2.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-9cdc5d048fe2#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.24,
        "x": 0.73,
        "y": 0.22
      },
      "kind": "callout",
      "text": "Perspectives 2025 and beyond: Drive growth momentum, sustain Eylea, forge next wave, prepare for Asundexian, stabilize Xarelto.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "845ad5a3-c72a-4365-a2b2-b0b502459f3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Perspectives 2025 and beyond: Drive growth momentum of Nubeqa and Kerendia; Sustain Eylea Market Position; Forge next wave of growth with Acoramidis and Elinzanetant; Prepare for Asundexian Stroke; Stabilize Xarelto after LoE impact.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-2301-748f-910f-3e4c21b42f27",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.04,
        "y": 0.235
      },
      "kind": "chart",
      "text": "Stacked area chart showing revenue composition across 2023, 2024-2026, and 2027+",
      "attrs": null,
      "subkind": "area-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c10ff3cc-5095-494e-a27e-9401f50c6957",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.15,
        "x": 0.04,
        "y": 0.35
      },
      "kind": "list",
      "text": "New Launch Assets, Nubeqa/Kerendia, Xarelto, Eylea, Base Business",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc8bb087-bd56-45cb-9fcc-514ae811f331",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Net Sales: €18.1bn",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-2301-748f-910f-411791aeaae2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.53,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "Phase III read-out expected in H2 2025",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff9aee3a-c691-49e9-922b-1c3db92c1f8e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.06,
        "y": 0.05
      },
      "kind": "title",
      "text": "Building Momentum for Long-Term Growth as of 2027+",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f61554c2-c911-4b24-95a1-28a6d162eb1d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "roadmap",
      "slug": null,
      "matchId": "fbae555c-f0f0-4b4d-82ba-26ac2bd7c440",
      "evidence": "Visual timeline of strategic portfolio evolution",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 8,
      "from": 6,
      "beatId": "216e1992-f7c2-44d9-a8ed-b37a049d3f14",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The slides highlight the company's strategic agenda and growth momentum",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "6ade2762-544e-41aa-adcf-f0724dca9dce",
      "evidence": "The slides highlight the company's 'why', 'what', and 'how'",
      "position": 1,
      "objective": "Why is Bayer's strategic agenda important?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}